Discounted Cash Flow Rating

Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Simple Moving Average

Buy

Exponential Moving Average

Strong Buy

Relative Strength Index

Strong Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Buy

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Buy

A

CATALENT, INC. (CTLT)

Pharmaceutical Preparations

https://www.catalent.com

Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.

14 SCHOOLHOUSE ROAD
SOMERSET, NJ

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/31/2014

Market Cap

10,777,359,000

Shares Outstanding

180,640,000

Weighted SO

180,641,272

Total Employees

N/A

Upcoming Earnings

09/03/2024

Similar Tickers

IQV --.--%

WST --.--%

CRL --.--%

BIO --.--%

TFX --.--%

Beta

1.1610

Last Div

0.0000

Range

31.8-60.2

Chg

-0.2600

Avg Vol

1858164

Mkt Cap

10777359000

Exch

NYSE

Country

US

Phone

732 537 6200

DCF Diff

6.4894

DCF

47.1606

Div Yield

0.0000

P/S

2.5982

EV Multiple

229.4906

P/FV

3.0014

Div Yield %

0.0000

P/E

-9.7817

PEG

-0.6370

Payout

0.0000

Current Ratio

2.5055

Quick Ratio

1.7408

Cash Ratio

0.1609

DSO

123.7199

DIO

84.3487

Op Cycle

208.0686

DPO

41.2980

CCC

166.7706

Gross Margin

0.1967

Op Margin

-0.2093

Pretax Margin

-0.2951

Net Margin

-0.2671

Eff Tax Rate

0.0948

ROA

-0.1122

ROE

-0.2798

ROCE

-0.0978

NI/EBT

0.9052

EBT/EBIT

1.4101

EBIT/Rev

-0.2093

Debt Ratio

0.5051

D/E

1.3819

LT Debt/Cap

0.5774

Total Debt/Cap

0.5802

Int Coverage

-3.5720

CF/Debt

0.0515

Equity Multi

2.7358

Rec Turnover

2.9502

Pay Turnover

8.8382

Inv Turnover

4.3273

FA Turnover

1.1106

Asset Turnover

0.4199

OCF/Share

1.4121

FCF/Share

-0.6758

Cash/Share

0.8901

OCF/Sales

0.0620

FCF/OCF

-0.4786

CF Coverage

0.0515

ST Coverage

4.5088

CapEx Coverage

0.6763

Div&CapEx Cov

0.6763

P/BV

3.0014

P/B

3.0014

P/S

2.5982

P/E

-9.7817

P/FCF

-87.6208

P/OCF

42.1716

P/CF

42.1716

PEG

-0.6370

P/S

2.5982

EV Multiple

229.4906

P/FV

3.0014

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Dec 14, 05:08 Novo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close Seeking Alpha Nov 18, 07:52 Wall Street Breakfast: What Moved Markets Benzinga Nov 15, 14:26 Catalent's Q1 Performance Beat Expectations: Analyst Says Main Focus On Manufacturing Outlook For Sarepta's Gene Therapy Benzinga Nov 15, 12:34 Stocks Inch Higher On Soft PPI, 'Magnificent 7' Retest 2021 Record Highs: What's Driving Markets Wednesday? Investing.com Nov 13, 13:43 Retailers Get Ready to Report Earnings Amidst Growing Fears of a Consumer Slowdown Seeking Alpha Nov 04, 08:04 Wall Street Breakfast: What Moved Markets Seeking Alpha Nov 04, 08:04 Wall Street Breakfast: What Moved Markets Benzinga Oct 31, 15:03 What's Going On With Biotech Contract Service Firm Catalent Stock Today?

Revenue Product Segmentation